\-\ Texto\\:\\ \ \(0\)\
\-\ ataxia\\.\\ \\ no\\ focal\\ neurological\\ deficit\\.\ \(0\)\
\-\ surgical\\ excision\\.\\ chemotherapy\\ pending\ \(0\)\
\-\ \\â\\€\\¢\\ enhancing\\ intraventricular\\ mass\\ occupying\\ the\\ 4th\\ ventricle\\.\ \(0\)\
\-\ \\â\\€\\¢\\ hydrocephalus\ \(0\)\
\-\ \\â\\€\\¢\\ tiny\\ nodules\\ of\\ abnormal\\ leptomeningeal\\ enhancement\\ adjacent\\ to\\ cervical\\ spinal\\ cord\\ and\\ in\\ the\\ interpeduncular\\ cistern\\.\ \(0\)\
\-\ medulloblastoma\\ with\\ leptomeningeal\\ spread\ \(0\)\
\-\ \\â\\€\\¢\\ medulloblastoma\\ \\(pnet\\)\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\ \(4\)\
\-\ 2\\ year\\ old\\ boy\\ with\\ a\\ 1\\ month\\ history\\ of\\ ataxia\\ and\\ nausea\\ and\\ vomiting\\.\ \(1\)\
\-\ the\\ most\\ common\\ posterior\\ fossa\\ masses\\ are\\ astrocytoma\\ and\\ medulloblastoma\\ \\(pnet\\ \\-\\ primitive\\ neuroectodermal\\ tumor\\)\\.\\ \\ astrocytomas\\ are\\ most\\ often\\ fluid\\ secreting\\ pilocytic\\ astrocytoma\\,\\ who\\ gr1\\,\\ and\\ lateral\\ in\\ the\\ cerebellar\\ hemisphere\\.\\ \\ midline\\ masses\\ involving\\ the\\ fourth\\ ventricle\\ are\\ usually\\ medullblastoma\\,\\ that\\ arise\\ in\\ the\\ vermis\\ and\\ secondarily\\ invade\\.\\ \\ measured\\ by\\ incidence\\,\\ ependymoma\\ is\\ in\\ third\\ place\\.\\ pmid\\:\\ 16088251\\ pmid\\:\\ 19082611\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.31156766040126316\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.2264908632530546\ \(0\)\
\-\ pmid\\:\\ 0\\.21950972358476376\ \(0\)\
\-\ pnet\\:\\ 0\\.21482762348852003\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.21148569921690208\ \(0\)\
\-\ ataxia\\:\\ 0\\.1942176684343736\ \(0\)\
\-\ ependymoma\\:\\ 0\\.16895267902487665\ \(0\)\
\-\ gr1\\:\\ 0\\.15993448905707827\ \(0\)\
\-\ medullblastoma\\:\\ 0\\.15993448905707827\ \(0\)\
\-\ 16088251\\:\\ 0\\.15993448905707827\ \(0\)\
\-\ 19082611\\:\\ 0\\.15993448905707827\ \(0\)\
\-\ ventricle\\:\\ 0\\.14722867561259134\ \(0\)\
\-\ masses\\:\\ 0\\.1361669976273891\ \(0\)\
\-\ secondarily\\:\\ 0\\.1356302081159179\ \(0\)\
\-\ interpeduncular\\:\\ 0\\.1317180926854204\ \(0\)\
\-\ invade\\:\\ 0\\.12711836626989373\ \(0\)\
\-\ secreting\\:\\ 0\\.12460954620663503\ \(0\)\
\-\ and\\:\\ 0\\.12399251488940731\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.12241520691250753\ \(0\)\
\-\ the\\:\\ 0\\.119731262582542\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.1195659522148402\ \(0\)\
\-\ primitive\\:\\ 0\\.11430456867956183\ \(0\)\
\-\ are\\:\\ 0\\.11384540978215547\ \(0\)\
\-\ vermis\\:\\ 0\\.11188254004500706\ \(0\)\
\-\ tiny\\:\\ 0\\.11078644360024588\ \(0\)\
\-\ occupying\\:\\ 0\\.10878062045359872\ \(0\)\
\-\ intraventricular\\:\\ 0\\.10421738069597214\ \(0\)\
\-\ most\\:\\ 0\\.10409433452127682\ \(0\)\
\-\ in\\:\\ 0\\.09951493240575347\ \(0\)\
\-\ measured\\:\\ 0\\.09863430312966569\ \(0\)\
\-\ cistern\\:\\ 0\\.0971088342171868\ \(0\)\
\-\ pilocytic\\:\\ 0\\.09593175918599271\ \(0\)\
\-\ deficit\\:\\ 0\\.09461625485244297\ \(0\)\
\-\ choroid\\:\\ 0\\.09379107512209373\ \(0\)\
\-\ hemisphere\\:\\ 0\\.09359070913787085\ \(0\)\
\-\ 4th\\:\\ 0\\.09206524022539196\ \(0\)\
\-\ papilloma\\:\\ 0\\.09170374632984085\ \(0\)\
\-\ arise\\:\\ 0\\.09152575665088032\ \(0\)\
\-\ plexus\\:\\ 0\\.0901633757311328\ \(0\)\
\-\ place\\:\\ 0\\.0901633757311328\ \(0\)\
\-\ spread\\:\\ 0\\.0898387028821903\ \(0\)\
\-\ fourth\\:\\ 0\\.08967859370737336\ \(0\)\
\-\ incidence\\:\\ 0\\.08608817230790394\ \(0\)\
\-\ pending\\:\\ 0\\.08225414980293362\ \(0\)\
\-\ neurological\\:\\ 0\\.08215010301212902\ \(0\)\
\-\ cerebellar\\:\\ 0\\.08184161705679982\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.0816389346515135\ \(0\)\
\-\ nodules\\:\\ 0\\.07946238514358325\ \(0\)\
\-\ excision\\:\\ 0\\.07885023902198159\ \(0\)\
\-\ fossa\\:\\ 0\\.07850980438757296\ \(0\)\
\-\ nausea\\:\\ 0\\.07682352391720004\ \(0\)\
\-\ third\\:\\ 0\\.07614769507830861\ \(0\)\
\-\ midline\\:\\ 0\\.07521531249270064\ \(0\)\
\-\ cord\\:\\ 0\\.07413192027515704\ \(0\)\
\-\ vomiting\\:\\ 0\\.07400108509486931\ \(0\)\
\-\ cervical\\:\\ 0\\.07162747824483233\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07101226309341223\ \(0\)\
\-\ spinal\\:\\ 0\\.07101226309341223\ \(0\)\
\-\ involving\\:\\ 0\\.07004990875079127\ \(0\)\
\-\ boy\\:\\ 0\\.06841208361136066\ \(0\)\
\-\ often\\:\\ 0\\.06525518320618637\ \(0\)\
\-\ adjacent\\:\\ 0\\.06482517243971217\ \(0\)\
\-\ usually\\:\\ 0\\.06295871193477076\ \(0\)\
\-\ enhancing\\:\\ 0\\.06264901498054905\ \(0\)\
\-\ month\\:\\ 0\\.06083599388384597\ \(0\)\
\-\ abnormal\\:\\ 0\\.06008343917723093\ \(0\)\
\-\ focal\\:\\ 0\\.059820237411306335\ \(0\)\
\-\ fluid\\:\\ 0\\.05774238912910906\ \(0\)\
\-\ enhancement\\:\\ 0\\.0575628369678345\ \(0\)\
\-\ common\\:\\ 0\\.05671596450110078\ \(0\)\
\-\ who\\:\\ 0\\.05657067223756338\ \(0\)\
\-\ tumor\\:\\ 0\\.052309961965988395\ \(0\)\
\-\ posterior\\:\\ 0\\.051714975227218525\ \(0\)\
\-\ lateral\\:\\ 0\\.04963175089616336\ \(0\)\
\-\ surgical\\:\\ 0\\.04860712754554217\ \(0\)\
\-\ that\\:\\ 0\\.04339970126077021\ \(0\)\
\-\ by\\:\\ 0\\.0424691771549201\ \(0\)\
\-\ with\\:\\ 0\\.03916561506497079\ \(0\)\
\-\ of\\:\\ 0\\.03914222759331086\ \(0\)\
\-\ history\\:\\ 0\\.03820882767823943\ \(0\)\
\-\ mass\\:\\ 0\\.038200368410141364\ \(0\)\
\-\ no\\:\\ 0\\.032521448436849516\ \(0\)\
\-\ year\\:\\ 0\\.03082048220628257\ \(0\)\
\-\ old\\:\\ 0\\.029598331692709423\ \(0\)\
\-\ is\\:\\ 0\\.027387857454910534\ \(0\)\
\-\ to\\:\\ 0\\.02500179186923827\ \(0\)\
